Clinical Trial Update: Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal Enuresis

View source ↗

Summary

A trial investigating serum copeptin as a biomarker to diagnose and classify polyuric primary monosymptomatic nocturnal enuresis; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monosymptomatic Nocturnal Enuresis

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Primary Monosymptomatic Nocturnal Enuresis, Copeptin | Status: NOT_YET_RECRUITING